|
Symbol
|
DSDCBL | QQHRCH | RMAZVV | LBBRDU |
|---|---|---|---|---|
| Name | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
AstraZeneca Plc. / Novo Nordisk AS (B) / Roche AG | AstraZeneca / GlaxoSmithKline / Sanofi-Aventis | AstraZeneca Plc. / BioNTech SE / Novartis AG | AstraZeneca Plc. / BioNTech SE / Novartis AG |
|
Issuer
|
|
|
|
|
|
Date of maturity
|
19.06.2026 | 30.12.2026 | 30.03.2027 | 08.04.2027 |
| Bid | 53.75 | 96.14 | 97.80 | 96.40 |
| Ask | - | 96.94 | 98.80 | 97.40 |